OCTAVE SPECIALTY GROUP INC
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
(a) Unregistered Sales of Equity Securities —No matters require disclosure.
| Octave Specialty Group, Inc. | 46 | Third Quarter 2026 Form 10-Q |
|---|
(b) Purchases of Equity Securities By the Issuer and Affiliated Purchasers
On November 12, 2024, Octave's Board of Directors authorized a share repurchase program, under which Octave was authorized to opportunistically repurchase up to $50,000 of the Company’s common shares at management’s discretion over the period ending on December 31, 2026. Additionally, when restricted stock unit awards issued under Octave's Long Term Incentive Plan vest or settle, they become taxable compensation to employees. Shares withheld to cover the employee's portion of withholding taxes are included in shares purchased.
The following table includes information about the Company's purchases of its common shares during the third quarter of 2026:
| Jul-2026 | Aug-2026 | Sep-2026 | Third Quarter 2026 | |
|---|---|---|---|---|
| Total Shares Purchased | 34,411 | — | 2,589 | 37,000 |
| Average Price Paid Per Share | $6.09 | $— | $4.54 | $5.98 |
| Total Number of Shares Purchased as Part of Publicly Announced Plan | — | — | — | — |
| Maximum Dollar Value That may Yet be Purchased Under the Plan | $8,449 | |||
The following table shows open market shares repurchased by year under Octave's November 12, 2024 share repurchase program:
| ($ in thousands, except per share) · Year Ended December 31, · YTD2026 | |||||
|---|---|---|---|---|---|
| 2024 · 2025 | |||||
| Shares repurchased | 937,141 | 3,434,745 | 0 | ||
| Total cost | $11,678 | $29,942 | $— | ||
| Average purchase price per share | $12.48 | $8.72 | $— | ||
| Unused authorization amount | $8,449 | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.